Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study

2015 ◽  
Vol 16 (4) ◽  
pp. 395-405 ◽  
Author(s):  
Bohuslav Melichar ◽  
Antoine Adenis ◽  
A Craig Lockhart ◽  
Jaafar Bennouna ◽  
E Claire Dees ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Aurora Kinase ◽  
Small Cell ◽  
Oesophageal Adenocarcinoma ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Aurora Kinase A ◽  
Phase 2 Study

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Benjamin Besse ◽  
David Planchard ◽  
Anne-Sophie Veillard ◽  
Laurent Taillade ◽  
David Khayat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study

P60.01 Investigation of Aurora Kinase A as a Potential Biomarker of Radiation in Non-Small Cell Lung Cancer (NSCLC)

2021 ◽  
Vol 16 (10) ◽  
pp. S1163-S1164
Author(s):  
T. Mitchell ◽  
T. Jones ◽  
S. Danson ◽  
M. Glover ◽  
J. Bury ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Aurora Kinase ◽  
Small Cell ◽  
Small Cell Lung ◽  
Aurora Kinase A ◽  
Potential Biomarker ◽  
Kinase A
Sign in / Sign up

Export Citation Format

Share Document